rs199562036
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001035.3(RYR2):c.11880+13_11880+16delACTG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0137 in 1,401,478 control chromosomes in the GnomAD database, including 188 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001035.3 intron
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 2Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
- catecholaminergic polymorphic ventricular tachycardia 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RYR2 | ENST00000366574.7 | c.11880+13_11880+16delACTG | intron_variant | Intron 88 of 104 | 1 | NM_001035.3 | ENSP00000355533.2 | |||
| RYR2 | ENST00000661330.2 | c.11904+13_11904+16delACTG | intron_variant | Intron 89 of 105 | ENSP00000499393.2 | |||||
| RYR2 | ENST00000609119.2 | n.*2972+13_*2972+16delACTG | intron_variant | Intron 87 of 103 | 5 | ENSP00000499659.2 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1621AN: 152210Hom.: 18 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0111 AC: 2752AN: 248142 AF XY: 0.0119 show subpopulations
GnomAD4 exome AF: 0.0140 AC: 17543AN: 1249150Hom.: 170 AF XY: 0.0141 AC XY: 8942AN XY: 632182 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0106 AC: 1619AN: 152328Hom.: 18 Cov.: 32 AF XY: 0.0101 AC XY: 750AN XY: 74488 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:4
Variant summary: RYR2 c.11880+13_11880+16delACTG alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. The variant allele was found at a frequency of 0.011 in 248142 control chromosomes in the gnomAD database, including 25 homozygotes. The observed variant frequency is approximately 443 fold of the estimated maximal expected allele frequency for a pathogenic variant in RYR2 causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is benign. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
11880+13_11880+16delACTG in intron 88 of RYR2: This variant is not expected to h ave clinical significance because it is not located within the splice consensus sequence and has been identified in 1.6% (125/7922) of European American chromos omes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). -
The variant is found in ARVC, CPVT, POSTMORTEM, ARRHYTHMIA, CARDIOMYOPATHY panel(s). -
not provided Benign:2
- -
- -
Catecholaminergic polymorphic ventricular tachycardia Benign:1
- -
Arrhythmogenic right ventricular cardiomyopathy Benign:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at